Login / Signup

Efficacy of nobiletin in improving hypercholesterolemia and nonalcoholic fatty liver disease in high-cholesterol diet-fed mice.

Young-Je KimDae Seong YoonUn Ju Jung
Published in: Nutrition research and practice (2021)
The present study suggests that NOB may serve as a potential therapeutic agent for the treatment of HCD-induced hypercholesterolemia and NAFLD.
Keyphrases
  • low density lipoprotein
  • cardiovascular events
  • physical activity
  • high glucose
  • diabetic rats
  • weight loss
  • cardiovascular disease
  • drug induced
  • metabolic syndrome
  • oxidative stress
  • adipose tissue
  • liver fibrosis